News
1Biomarkers and Clonal Dynamics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
1Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 2Department of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research ...
1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama. 2Division of Pediatric Hematology/Oncology, University of Alabama at Birmingham, Birmingham, ...
SELLAS Life Sciences Group announced that its CDK9 inhibitor tambiciclib (SLS009) improved median overall survival (OS) in patients with relapsed or refractory acute myeloid leukemia (AML) in a phase ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license ...
Public health groups and individual scientists together sued the NIH over the discontinuation of hundreds of research grants worth more than $2.4 billion. The lawsuit, filed by NIH-funded scientists ...
Copyright held by the owner/author(s).
1Department of Pediatric Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts. *Corresponding Author: Junne Kamihara, Department of ...
Copyright held by the owner/author(s).
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license This work ...
1Department of Pathology, The University of Chicago, Chicago, Illinois. 2Department of Medicine, The University of Chicago, Chicago, Illinois. Search for other works by this author on: 1Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results